tradingkey.logo

Prenetics Global Ltd

PRE
12.345USD
-0.375-2.95%
Fechamento 11/06, 16:00ETCotações atrasadas em 15 min
159.18MValor de mercado
PerdaP/L TTM

Prenetics Global Ltd

12.345
-0.375-2.95%

Mais detalhes de Prenetics Global Ltd Empresa

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Informações de Prenetics Global Ltd

Código da empresaPRE
Nome da EmpresaPrenetics Global Ltd
Data de listagemJul 06, 2021
CEOMr. Joel Neoh
Número de funcionários285
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 06
EndereçoUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Cidade
Bolsa de valoresLondon Stock Exchange
PaísHong Kong
Código postal- -
Telefone85222109588
Sitehttps://ir.prenetics.com/
Código da empresaPRE
Data de listagemJul 06, 2021
CEOMr. Joel Neoh

Executivos da empresa Prenetics Global Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Mr. Alan Thomas
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Ms. Jordan Lemerande
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Hong Kong
14.27M
46.59%
Taiwan
7.09M
23.16%
The United States
5.51M
18.00%
United Kingdom
2.78M
9.08%
Rest of the world
972.00K
3.17%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: qui, 2 de out
Atualizado em: qui, 2 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dennis (Lo Yuk Ming)
7.69%
Genetel Bioventures Ltd
4.90%
Lawrence (Tzang Chi Hung)
4.29%
Eastspring Investments (Singapore) Limited
3.42%
Aspex Management (HK) Limited
2.76%
Outro
76.94%
Investidores
Investidores
Proporção
Dennis (Lo Yuk Ming)
7.69%
Genetel Bioventures Ltd
4.90%
Lawrence (Tzang Chi Hung)
4.29%
Eastspring Investments (Singapore) Limited
3.42%
Aspex Management (HK) Limited
2.76%
Outro
76.94%
Tipos de investidores
Investidores
Proporção
Individual Investor
13.28%
Corporation
4.90%
Investment Advisor
3.86%
Hedge Fund
2.76%
Research Firm
2.57%
Investment Advisor/Hedge Fund
0.07%
Outro
72.56%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
23
1.16M
9.26%
-1.28M
2025Q2
30
3.73M
32.59%
-1.27M
2025Q1
31
3.72M
35.24%
-295.48K
2024Q4
35
3.71M
34.90%
-336.29K
2024Q3
37
3.69M
34.65%
-448.54K
2024Q2
38
3.76M
35.34%
-535.47K
2024Q1
88
5.56M
55.93%
+1.27M
2023Q4
94
4.17M
42.91%
+30.90K
2023Q3
99
4.01M
43.06%
+108.37K
2023Q2
98
3.11M
36.85%
-918.88K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dennis (Lo Yuk Ming)
962.96K
8.41%
--
--
Apr 24, 2025
Genetel Bioventures Ltd
613.79K
5.36%
--
--
Sep 30, 2024
Lawrence (Tzang Chi Hung)
537.10K
4.69%
--
--
Apr 24, 2025
Eastspring Investments (Singapore) Limited
427.96K
3.74%
--
--
Jun 30, 2025
Aspex Management (HK) Limited
346.15K
3.02%
--
--
Jun 30, 2025
Nomura Securities Co., Ltd.
321.82K
2.81%
-11.70K
-3.51%
Jun 30, 2025
Chun (Lo Hoi)
162.62K
1.42%
--
--
Apr 24, 2025
BlackRock Institutional Trust Company, N.A.
22.75K
0.2%
+22.75K
--
Jun 30, 2025
Stevens Capital Partners
17.38K
0.15%
+17.38K
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
8.92K
0.08%
+6.80K
+320.15%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: há 20 horas
Atualizado em: há 20 horas
Nome
Proporção
iShares Micro-Cap ETF
0.02%
iShares Micro-Cap ETF
Proporção0.02%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Data
Tipo
Proporção
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
KeyAI